chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Another friend mentioned that the same thing had happened to her where first dose was given, but second dose was not available at the time of the next visit; Another friend mentioned that the same thing had happened to her where first dose was given, but second dose was not available at the time of the next visit; Another friend mentioned that the same thing had happened to her where first dose was given, but second dose was not available at the time of the next visit; No additional adverse effects reported; This spontaneous report was received from consumer via company representative, referring to a female patient of unknown age (also reported as "unspecified patients": conflicting information). The patient's pertinent medical history, concurrent conditions, previous drug reactions or allergies, and concomitant medications were not reported.  On an unknown date, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) as prophylaxis (route of administration, anatomical location, lot number and expiration dates were not reported).  On an unknown date, it was reported that second dose was not available at the time of the next visit (circumstance or information capable of leading to medication error, inappropriate schedule of product administration, and product availability issue). No additional adverse effects reported.  This is one of two reports received from the same reporter.; Sender's Comments:  US-009507513-2007USA010521:
the patient had no symptoms or adverse events following administration; nurse who reports administration of vaccines following temperature excursion.; This spontaneous report has been received from a nurse referring to a patient of an unknown age and gender.  The patient's medical history, concurrent conditions, concomitant medications, and previous drug allergies or reactions were not provided.  On 29-JUN-2022, the patient was vaccinated with  a improperly stored hepatitis b vaccine (recombinant) (RECOMBIVAX HB) at a dose of 0.5 milliliter once, lot number T032918 was determined to be valid for vial formulation for hepatitis b vaccine (recombinant) (RECOMBIVAX HB), expiration date: 12-NOV-2022 (vaccination scheme, and route of administration were not provided), and  rotavirus vaccine, live, oral, pentavalent (ROTATEQ) orally at a dose of  2ml once, lot number U038864, expiration date: 22-APR-2023 (vaccination scheme was not provided), as prophylaxis following a temperature excursion of minus 0.8 degrees Celsius (C) for 1 hour 10 minutes (product storage error), there was stated that no previous temperature excursion occurred. The patient had no symptoms or adverse events following administration of the vaccine.  This is one of several cases from the same reporter.
Vaccine was administered at 8:56 AM. Patient began experiencing lightheadedness at 9:11AM, notified Dr.  Vitals Taken : Temperature: 97.7   Spo2: 97 %   Pulse: 77    BP: 102/64 mmHg. Per Dr. observe patient an additional (30) Minutes.  After (30) Minute Observation symptoms resolved. Vital Taken after (30) Minutes; 9:46 AM Temperature : 97.9  Pulse: 82  BP: 120/82 mmHg   Spo2: 97% Dr. was notified. Had patient walk in hallway and per Dr. okay to release patient home. Patient advise he may go no nearest emergency room if symptoms return and/or may contact his PCP and/or our office for additional assistance if needed.
Started approximately 12 hours after injection:  Headache, Fatigue, Malaise, low grade fever with mild night sweats, achy/sore left  arm, red and itchy injection site Symptoms lasted approximately 36 hours except for achy/sore left arm and red itchy injection site.  Those  lasted about 72 hours.
given expired vaccine; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (given expired vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (given expired vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (given expired vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported. Treatment medications was not mentioned
he was prescribed with injections for his arthritis; This is a spontaneous report from a sponsored program. A contactable consumer (patient) reported that a male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: unknown) dose 1 via an unspecified route of administration on 13Feb2021 as single dose for COVID-19 immunization. Medical history was not reported. Concomitant medications were unspecified. Patient reported that he had an appointment from a physician, he was prescribed with injections for his arthritis in Feb2021, and he had been injected with the medication and he was asking if it's gonna affect the first dose. The outcome of event was unknown.  Follow-up attempts completed. No further information expected.
Raised, red bumps on left upper arm spreading down to elbow to around to inside of arm. Complained of some dizziness, went to private physician. Physician prescribed Zyrtec, Cortisone cream-may also use Benadryl as needed.  Rash spread from arm across back to chest to right arm.
pt called and said that she has tingling in toes and fingers on both sides; started the previous night but is improving -- said that she has had this before with other vaccines
jaw seized and she became stiff, fell off the couch and landed on the floor. Brief 1 to 2-minute episode of shaking where she slid to the floor from the couch.  She states that afterwards she felt very drained and her muscles were aching.
Three-inch diameter red welt at injection site, warmth and pain at injection site, moderate to severe headache, muscle, and joint paint lasting approximately one week.
10 days after receiving  Janssen COVID-19  vaccine I suddenly developed severe pain to my right leg. Pain was so severe I could not walk, I dragged myself into the medicine pantry and believing it could possibly be a thrombosis, I instantly took 2 baby aspirins. Although I wanted to call for help, I was too far from my phone therefore I began to massage the area and remained in place until the pain subsided enough to regain movement.
After patient received vaccine she started to pass out while seated,  Her body started to shake and her eyes rolled in her head.  The  paramedics were called and evaluated her but did not consider this an allergic reaction but a vasovagal response due to fear.
Information has been received from a physician concerning an approximately 3-month-old male with a history of stomach problems who in approximately October 2006, was vaccinated PO with the first 2.0 mL dose of rotavirus vaccine.  The physician reported that in approximately October 2006, the patient developed diarrhea and vomiting. Unspecified medical attention was sought and the patient subsequently recovered.  In December 2006, at approximately 5 months of age, the patient was vaccinated with the second 2.0 mL dose of rotavirus vaccine and again developed diarrhea and vomiting.  The patient subsequently recovered.  It was noted that the patient would not be getting the third dose.  Additional information has been requested.
Drowsiness; muscle weakness (legs); nausea; diarrhea; and dizziness starting within 30 minutes of vaccine lasting approximately 36  hours.
BlurredVision diaphoresis, thirsty, tinnitus  Narrative: Reaction occurred within 5 minutes post vaccination and employee was taken to the ED, later discharged to home.
Case number PHHY2011CA84226 is an initial literature report received on 16 Sep 2011. Authors described about novel influenza (H1N1) infection in pediatric renal transplant recipients who were vaccinated with influenza H1N1 vaccine. This report refers to a pediatric patient (age less than 18 years) of unknown gender. The patient's medical history included renal transplant. The patient received induction therapy consisting of five doses of daclizumab (1mg/kg) at two weeks intervals starting the day of transplant. Concomitant medications also included prednisone 0.11 mg/kg/day, tacrolimus 0.04 mg/kg/day and mycophenolate mofetil 1000 mg/BSA/day. The patient was vaccinated with influenza H1N1 vaccine (manufacturer and batch number: unknown) on an unspecified date. Ten days after vaccination, the patient developed H1N1 influenza infection which got confirmed. The patient received either oseltamivir or antibiotic medications and supportive treatment for the same. The length of H1N1 course was in range between 3 to 14 days. Authors stated that the clinical course of influenza (H1N1) infection in pediatric renal transplant recipients was generally mild and posed neither significant morbidity nor mortality when supportive treatment and oseltamivir were administered. Authors also mentioned that it is unlikely that H1N1 vaccine administration played a significant protective role as longest interval between vaccine administration and presentation with illness observed was only 10 days.
The patient called questioning potential side effects of the second Shingrix vaccine around January 29th. We discussed all of the  potential side effects, as documented by GSK. The patient stated she felt really tired, achy and just felt flu-like. She stated it was slowly getting better day by day. I told her if it is bothersome, then she should definitely contact her provider. She said she would if she still felt sick on Monday 2/1. She called her provider and made an appointment. In the chart notes, it states that everything appears to be within normal limits. No treatment was given. On 2/9, the patient called for copies of her receipts for her insurance. It was then that is was discovered that she had received the two series vaccines 4 weeks and 5 days apart. Patient was made aware and was told we will call the prescriber to see what he recommends. According to CDC, the vaccine should be re-administered if there is less than a 4 week interval. Doctor was made aware. He said that is the patient would like to receive another one, then that is fine, but he thinks she should be ok. I informed the patient of the doctor's recommendations on 2/10/2021. She declined another vaccine at this time, because she stated she doesn't want to go through that again. A Risk report has been filled out.
Rashes, itching, redness, swelling, blister. Pt took off the bandage (because pt is allergic to the bandage) at night and left it open without cover up.
Received a regular flu shot on 9/30. On 10/01, I noticed that there was a red, hot, somewhat itchy,  large circle surrounding the site of injection. My arm was also more sore than usual. I iced it for two days and after 4 days, it was still there. I went back to the health center on day 4 where the doctor said I have a localized reaction to the shot. I was given Triamcinolone Acetonide Ointment USP, .5%, which was to be applied until the redness and hotness disappeared.
day p/vax pt devel fever & aching all over body;14AUG96 pt c/o aching & feeling miserable;15AUG96 pt returned to MD office w/fever 100, flushed, mixed blotches, inj site rxn characterized by redness, swelling, hives, itching;
Patient awoke 10/12/10 with redness, swelling to deltoid described as half dollar size round, tenderness, achy arm. Advised ice, gentle massage and Ibuprofen.
PATIENT CALLED AND SAID SHE CANT LIFT HER HAND AND ITS SORE.
First days I've had a sore arm, feeling tired and having headaches. By now, I'm even feeling more sore than before, headaches are constant and I have joint pain, fever and sometimes is even hard to  breathe.
Vaccine administered around 11:30, and patient reported severe itching within 20 minutes.  She was taken to the ED and given solumedrol, Benadryl and Pepcid.  Symptoms resolved and patient discharged home.
APPROXIMATELY 30 MINUTES AFTER INJECTION, PATIENT RETURNED TO PHARMACY STATING SHE HAD VISUAL DISTURBANCES THINKING IT COULD BE A REACTION TO HER VACCINE.   SHE NOTICED BLACK SPOTS IN HER VISION AND EVENTUALLY HAD TUNNEL VISION.   SHE STATES THAT SHE DIDN'T EAT MUCH DURING THE DAY, BLOOD PRESSURE WAS NORMAL PER OUR READING, AND INJECTION SITE SHOWED NO VISIBLE SITES OF REACTION.     AFTER SITTING FOR AN ADDITIONAL 30 MINUTES, SHE FELT WELL ENOUGH TO GO HOME BY HERSELF
Pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041L20A and 022M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 07-Jul-2021. In 2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy). At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) outcome was unknown.            The patient's concomitant medication was not reported. No treatment medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: Internal review on 20-Jul-2021 resulted in updates to the pregnancy details
Patient is a 38 years old nurse who immediately after vaccination on 3/14/03 described "itch all over her body ". After a few minutes she expressed it was increasing and started to scratch herself, specially in her back. The attending MD at the Smallpox vaccination clinic saw her; they did not observe any objective evidence of allergic reaction in her skin; and physical exam did not show any relevant signs or symptoms. She received Benadryl 50 mg p.o. She described some improvement, but since the immunization clinic was closing the patient was sent to the ER as a precaution for 1 hour observation; ER attending decided to administer a doses of prednisone IM, before sending the patient home and prescribed benadryl every 6 hours. Patient was daily followed by DHHS, disease control, and she complained of minor itch, with no evidence of skin lesions for the following 48 hours. On Sunday 3/16/03 she expressed to be experiencing headache and malaise. On Monday 3/17/03 we (DHHS Disease Control) asked her to attend her local ER for a consult. Attending MD did not find any objective evidence of allergic reaction, but made a clinical diagnosis, confirmed by X-Ray of severe acute sinusitis. Antibiotics were prescribed. Patient is improving and since 3/18/03 she experiences no more itch.
within 5 minutes of the vaccine administration patient had numbness/tingling of her lips, tongue, and face. She was given Benadryl, which she states improved her symptoms and she was able to sleep.  This morning (day after vaccine) she states that her tingling feeling has returned to her face, lips and tongue and she feels a globus sensation and constriction within her throat. She has taken a benadryl this morning with no improvement.  Patient was recommended to seek care in the ER.
This spontaneous report as received from a pharmacist refers to a 70 year old male patient. Patient was allergy to penicillin resulting in a rash. Approximately on an unknown date in April 2013 (reported as 6 months ago), the patient was vaccinated with a dose of ZOSTAVAX (Lot number and expiry date was not reported) VIAL 19400 PFU, 0.65 milliliter (ml), subcutaneously. Concomitant Medication were none. Approximately on an unknown date in April 2013 (reported as 3 to 4 days after receiving ZOSTAVAX), the patient experienced severe itching, psoriasis-like rash and was diagnosed with "Grover's disease" disease by an unspecified dermatologist. Patient sought medical attention for the same (contacted unspecified physician and pharmacist). Lab Diagnostic Studies Performed was none. Patient was treated with Prednisone, Clobetasol and Ambien. The outcome of the reported event was not recovered/not resolved. Additional information has been requested.
Information has been received from a physician concerning an 8 year old male patient with no known drug allergies or pertinent medical history who on 10-OCT-2002 (at the age of one) was vaccinated with the first dose of VARIVAX (Merck) (lot number not provided). There was no concomitant medication. The physician reported that on 10-JUL-2010 the patient developed shingles prior to receiving his second VARIVAX (Merck) vaccination. The child was treated with acyclovir and recovered on an unspecified date. The patient was seen by the physician. Additional information has been requested.
Information has been received from a 69 year old female consumer with high blood pressure and arthritis who on 27-JUL-2010 was vaccinated with a dose of PNEUMOVAX 23 (Manufacturer unknown) in her muscle in the upper side of her arm. Concomitant therapy included antibiotics (therapy unspecified), allergy pills (therapy unspecified), high blood pressure medicine (therapy unspecified) and arthritis medication (therapy unspecified). The consumer stated that she had gotten a "pneumonia shot", but she did not remember the name of it. She stated that on 30-JUL-2010 "on the third day of had the pneumonia shot", she experienced site injection pain, swelling, redness, cakiness, fever chills and an increase in temperature at the injection site as a result of receiving the pneumonia shot. There were no laboratory tests performed. At the time of this report, the consumer was recovering from site injection pain, swelling, redness, cakiness, fever chills and an increase in temperature at the injection site. The patient sought medical attention (she went to urgent care facility but she was not hospitalized). Additional information has been requested.
Patient received vaccine and after approximately 15 minutes he reported that his face felt swollen and was red. Reported that he has had this reaction before if allergic to something. Medical response called. Patient transported to ER via wheelchair by Medical Response team.
This spontaneous report as received from a Registered Nurse refers to multiple patients of unknown ages and genders. Medical history and current conditions were not reported. On an unknown dates over an unspecified 7 month period, the patients were vaccinated with improperly stored doses of M-M-R II lot number K0111888, expiration date 12-AUG-2016, and lot number L035674, expiration date 17-SEP-2017. Dose and route of administration were not provided. No other suspect or concomitant medications were reported. As reported, temperature: uncertain, surmising worst case 51 Fahrenheit degrees for 7 months; digital data logger was involved. Previous: uncertain. No adverse effects were reported. This is one of four reports received from the same source. Additional information had been requested.
Received vaccine on a Thursday.  For the next 3 night I would get a dull  headache with increased blood pressure.   On Sunday morning I woke up with severe burning pain in my stomach up to & including in my esophagus plus all the normal reactions - dull headache, tired, weak, nauseated, chills, achiness & no appetite.   The burning pain lasted about 12-14 hrs.  I had no fever as well as no vomiting.  continued to have other symptoms into the next day.   After Monday I was back to normal.
Severe muscle aches in the arm of the injection that progressed over the day. By the end of the next day, I had horrible joint aches (knees, shoulder, hands, hips, ankles)by evening time I could do nothing but lay with pillows supporting me. Fatigue accompanied the muscle pains.  Lasted 8 days.
His wife reportedly also tested positive but had no symptoms or signs of illness; This is a spontaneous report from a contactable consumer (patient) via a Pfizer sponsored program COVAX US support. A female patient of an unspecified age received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on 08Feb2021 at single dose for COVID-19 immunisation. Patient medical history and concomitant medications were not reported. Reports that he and his wife both had their first covid vaccine dose on 08Feb2021. Reports "she had a bad reaction several days later with severe weakness". Reports that he had to go to the ER on 15Feb2021 where they were both tested for covid (both testing positive) and then he was hospitalized on 17Feb2021 and was hospitalized for 6 days. His wife reportedly also tested positive but had no symptoms or signs of illness. She was tested Positive for Covid on 15Feb2021, after the first dose of the Covid vaccine was received on 08Feb2021. Reporter seriousness for Tested Positive for Covid on 15Feb2021, after the first dose of the Covid vaccine was received on 8Feb2021 was unspecified. States he was calling about the Covid19 Shot; verified Pfizer Covid19 Vaccine. States on 08Feb2021, his wife and he who were both  residents, went down to to get their first shot of the Pfizer vaccine. States they both got the shot and they had no symptoms before the shot. States he got very sick that week and became progressively worse after the shot. States he was okay for the first couple of days and then he got sicker and sicker and weaker and weaker. States he went to the ER on 15Feb2021 and he got a positive Covid test on 15Feb2021 in. States himself and his wife both tested positive for Covid. States they said at , they probably had Covid with no symptoms when they got the shot. States he went into the hospital on 17Feb2021 because he was very weak and had a fever. States it was a Wednesday that he went to hospital and he was there for 6 days. States he was all better now and he was treated with Remdesivir. States his wife had no symptoms all together throughout other than she also tested positive for Covid on 15Feb2021. States his question was, he was told by his primary care doctor although he was not 100% sure, they had to wait 90 days to get the second shot. States the pharmacist recommended to call Pfizer for recommendations on what they should do. Caller states they both tested negative for Covid at the end of March, about 2-3 weeks ago. Declines to complete a report for his wife. States she basically didn't have any symptoms other than maybe she was a little tired, not sure if that was from the vaccine or the Covid. States after she got shot, she took care of him. Caller and his wife received the first dose of the covid-19 vaccine on 08Feb2021, caller said that him and his wife both tested positive for covid that same day, caller states he was hospitalized on 17Feb2021. Outcome of event was recovered on an unspecified date in 2021.  Information about lot/batch number cannot be obtained. No follow-up attempts are needed. No further information is expected.
Following morning after vaccination, sudden hearing loss with initial ringing in the right ear.  Soon followed by vertigo, nausea & vomiting.   Nausea & vertigo resolved within 2 days. Diagnosed with sudden sensorineural hearing loss & still receiving treatment of steroids to resolve hearing loss as of now.
30 minutes after vaccination on left arm  2 inch round red spot, bigger than half dollar, hot and hard, sore
Shortly after I had weird  a slight feeling of things weren?t right.  In March 2022 I finally went to the doctor and was diagnosed with diabetes after lab test and feel this was linked. I had none of these symptoms before the vaccine which I got in September and October